The Distal U-Shaped Capsule Sparing Technique (DUS-CS) for Revision Breast Augmentation: A Consecutive Clinical Series of 223 Patients.

Abstract

Background: Capsular contracture is a common complication following breast augmentation with silicone implants, which often requires surgical revision, especially in advanced stages. A surgical gold standard for the treatment of capsular contracture is still under discussion. This article presents a novel capsule-sparing method for implant exchange in patients with capsular contracture.

Methods: This is a retrospective, descriptive, single-center technical study focusing on the detailed presentation, surgical rationale, and standardized execution of a novel capsule-sparing revision technique. The technique combines a U-shaped selective capsulectomy with the Double-Unit Superomedio-Central (DUS-CS) approach to preserve structurally intact capsule segments, minimize surgical trauma, and maintain implant position during revision surgery. The central and cranial parts of the capsule are removed, while the medial, lateral, and caudal parts are left in place. The newly inserted breast implant is limited and stabilized by the remaining capsule remnants. Possible implant dislocation is reduced, and soft tissue coverage is improved.

Results: A total of 223 patients have already undergone surgery using the DUS-CS technique between January 1, 2023, and November 21, 2025. Within the available follow-up period, no recurrence of capsular contracture, symmastia, or bottoming out were observed in the treated cohort.

Conclusions: This technique allows effective treatment of capsular contracture while avoiding the morbidity of total capsulectomy. Preliminary clinical experience demonstrates feasibility and safety, particularly in revision cases where maintenance of pocket geometry is essential. Larger studies are required to evaluate long-term outcomes and recurrence rates.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .